SCHEMBL951844

SCHEMBL951844

CC(I)C(=O)OC(=O)C(C)I

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.32
TSHR P16473 2/20 0.32
ALDH1A1 P00352 1/20 0.32
SOAT1 P35610 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL951508 0.87
SCHEMBL953463 0.87 TSHR (0.31) TSHR
SCHEMBL27576712 0.85
SCHEMBL951846 0.81 NAAA (0.37) ALDH1A1SOAT1
SCHEMBL2593980 0.80 SMN1; SMN2 (0.32) SMN1; SMN2TSHRTP53
SCHEMBL950803 0.79 SMN1; SMN2 (0.30) SMN1; SMN2
SCHEMBL1568541 0.78
SCHEMBL16377933 0.78
SCHEMBL26818524 0.78
SCHEMBL3137072 0.75 TSHR (0.33) TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119505178-B Cured product of organic phosphine modified unsaturated resin and polyhalogenated compound and preparation method thereof 浙江工业大学 2025-04-04 CN claimed
CN-119505178-A Cured product of organic phosphine modified unsaturated resin and polyhalogenated compound and preparation method thereof 浙江工业大学 2025-02-25 CN claimed
CN-117624613-A Degradable phosphorus/silicon composite antibacterial/flame-retardant material and preparation method thereof 浙江工业大学 2024-03-01 CN claimed
CN-119505178-B Cured product of organic phosphine modified unsaturated resin and polyhalogenated compound and preparation method thereof 浙江工业大学 2025-04-04 CN disclosed
CN-119505178-A Cured product of organic phosphine modified unsaturated resin and polyhalogenated compound and preparation method thereof 浙江工业大学 2025-02-25 CN disclosed
CN-117624613-A Degradable phosphorus/silicon composite antibacterial/flame-retardant material and preparation method thereof 浙江工业大学 2024-03-01 CN disclosed
US-20130030212-A1 COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER IDEMITSU KOSAN CO., LTD. (JP) 2013-01-31 US disclosed
US-20130023693-A1 COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20110009661-A1 COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER IDEMITSU KOSAN CO., LTD. (JP) 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130030212-A1 COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER ALAD, MMAB, MAT1A SMN1; SMN2 2540/4885TSHR 2845/4885ALDH1A1 313/4885
US-20130023693-A1 COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER ALAD, MMAB, MAT1A SMN1; SMN2 2540/4885TSHR 2845/4885ALDH1A1 313/4885
US-20110009661-A1 COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER ALAD, MMAB, MAT1A SMN1; SMN2 2540/4885TSHR 2845/4885ALDH1A1 313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.